ATORIS

40MG TBL FLM 30

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 26.02.2021
Interruption of marketing 15.12.2020 0138125, 0145808, 0148306, 0157852, 0200829, 0200836, 0204690, 0204694, 0225126, 0234341, 0234348, 0087051, 0093019, 0093021
Manufacturing reasons 25.02.2021
Resumption of marketing 09.06.2020
Interruption of marketing 05.05.2020 0138125, 0148306, 0148309, 0204690, 0204694, 0226035, 0234341, 0234348, 0087051, 0093019, 0093021
Manufacturing reasons 15.6.2020
Resumption of marketing 31.01.2020
Interruption of marketing 16.12.2019 0138125, 0147085, 0148306, 0148309, 0157852, 0200830, 0200839, 0204690, 0204694, 0218999, 0225127, 0225132, 0234341, 0234348, 0093019, 0093021
Manufacturing reasons 10.2.2020
Placing on the market 01.02.2006

All reports are available in the Overview.

Back to list